Breaking News Instant updates and real-time market news.

GME

GameStop

$21.22

0.12 (0.57%)

, MSFT

Microsoft

$72.49

0.09 (0.12%)

17:08
08/20/17
08/20
17:08
08/20/17
17:08

GameStop kicks off nationwide pre-orders for Microsoft Xbox One X

GameStop (GME) is offering fans the first chance to experience Microsoft's (MSFT) Xbox One X at GameStop Expo, as part of a multimillion dollar campaign to support the new system. Today, gamers can also pre-order their own Xbox One X - Microsoft's debut 4K UHD console - at GameStop locations nationwide or online at www.gamestop.com/xboxonex. Every year, fans travel to GameStop Expo to check out the newest games, consoles and exclusive collectibles. On August 27, it will also be the only place they can get their hands on Xbox One X, long before the system becomes available on November 7. GameStop is also boosting affordability with special trade-in guarantees for PowerUp Rewards members when used toward the purchase of an Xbox One X system.

GME

GameStop

$21.22

0.12 (0.57%)

MSFT

Microsoft

$72.49

0.09 (0.12%)

  • 24

    Aug

  • 05

    Sep

GME GameStop
$21.22

0.12 (0.57%)

05/26/17
MZHO
05/26/17
NO CHANGE
MZHO
GameStop should be bought on weakness, says Mizuho
Mizuho analyst San Phan says that the decline in GameStop's stock was caused by its unchanged fiscal 2017 guidance and the 2% year-over-year decline in the operating income of its tech brands business. The analyst says that the company's guidance is conservative, and he is more upbeat on the company;s outlook due to the success of the Nintendo (NTDOY) Switch. He strongly recommends buying GameStop's shares on weakness.
05/26/17
LOOP
05/26/17
NO CHANGE
Target $28
LOOP
Buy
GameStop shortfall in Technology Brands a reason for pause, says Loop Capital
Loop Capital analyst Anthony Chukumba believes GameStop's Technology Brands business heavily influences investor perception of the company's "terminal value" and he sees the profitability shortfall in that segment as something that gives him pause at a time when he says the company doesn't need "another thing to worry about." Noting GameStop reported much better than expected Q1 results in spite of the Tech Brands profit issue, Chukumba keeps a Buy rating on the stock, citing valuation.
05/01/17
RHCO
05/01/17
NO CHANGE
RHCO
GameStop to benefit from higher Switch production, says SunTrust
After Nintendo increased its production of the Switch console by 25%, SunTrust analyst David Magee says that the increase is positive for GameStop (GME). He thinks that the Switch will boost the retailer's comp sales growth by 1%-4% in 2017 and could raise its profit by 10%. According to the analyst, little of these increases are incorporated into Street estimates. He keeps a $28 price target and a Buy rating on the shares.
03/27/17
03/27/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Michaels (MIK) downgraded to Neutral from Overweight at Piper Jaffray with analyst Peter Keith citing his firm's Spring women's survey which showed 30%-40% of arts and crafts purchases are completed online. Further, the analyst's pricing analysis versus Amazon (AMZN) suggests Michaels is at a "notable premium" on 50 like-for-like items. Keith sees potential for price investment by Michaels over the coming years to make itself more competitive with Amazon. 2. Intuit (INTU) downgraded to Buy from Conviction Buy at Goldman with analyst Jesse Hulsing citing the more challenging Consumer Tax environment. Software/do-it-yourself share gains versus assisted are down versus prior years, including Intuit's, the analyst wrote. As a result, Hulsing lowered Inuit estimates and trimmed its price target to $134 from $135. 3. GameStop (GME) downgraded to Neutral from Buy at Hilliard Lyons with analyst Jeffrey Thomison saying 2017 guidance was "underwhelming" and he has increased concerns regarding the core video game retailing business. 4. Morgan Stanley (MS) downgraded to Sell from Neutral at Compass Point with analyst Charles Peabody saying he views shares as overvalued based on the elongated trajectory towards earning a competitive ROE and most of the benefits of Project Streamline have been priced in or realized. 5. KB Home (KBH) downgraded on valuation at JMP Securities with analyst Peter Martin downgraded the stock based on valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MSFT Microsoft
$72.49

0.09 (0.12%)

08/07/17
FBCO
08/07/17
NO CHANGE
Target $84
FBCO
Outperform
Microsoft new accounting standards to have little impact, says Credit Suisse
Credit Suisse analyst Michael Nemeroff notes that Microsoft recently hosted a conference call to discuss its new reporting standards to reflect ASC 606 and ASC 842, which will be in effect starting with Q1 results. The analyst estimates little to no impact to his 2018 and 2019 estimates given this accounting update. However, there is higher volatility in quarterly revenue with different seasonality patterns throughout the year versus the prior standard, he adds. Nemeroff reiterates an Outperform rating and $84 price target on the shares.
07/28/17
DBAB
07/28/17
DOWNGRADE
Target $180
DBAB
Hold
MicroStrategy downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Karl Keirstead downgraded MicroStrategy (MSTR) to Hold and cut his price target for the shares to $180 from $220 citing the "disappointing" Q2 results as well as the company's strategy shift. Last night's results marked the third consecutive quarter of license revenue declines, Keirstead tells investors in post-earnings research note. MicroStrategy is now pivoting to a "much more aggressive" spending strategy in response to competition from Tableau (DATA) and Microsoft (MSFT), the analyst adds. He believes the stock has more downside risk.
07/21/17
RAJA
07/21/17
NO CHANGE
Target $84
RAJA
Strong Buy
Microsoft price target raised to $84 from $77 at Raymond James
Raymond James analyst Michael Turits raised Microsoft's price target to $84 and reiterated his Strong Buy rating following the across-the-board Q4 beat on strong commercial bookings and cloud results. The analyst trimmed FY18 and FY19 earnings on the down margin guidance and higher taxes but expects margin expansion in FY19 as cloud margins continue to rise.
07/21/17
STFL
07/21/17
NO CHANGE
STFL
Microsoft should be bought on any weakness, says Stifel
Stifel analyst Brad Reback says that Microsoft reported "strong" Q4 results, as he noted that the growth of its cloud business, Azure, accelerated to 98% year-over-year, while its commercial bookings surged 30% year-over-year. He expects the company's operating profit and free cash flow to accelerate in coming quarters and raised his price target to $80 from $73 while keeping a Buy rating. .

TODAY'S FREE FLY STORIES

CELC

Celcuity

20:34
09/19/17
09/19
20:34
09/19/17
20:34
Syndicate
Celcuity 2.4M share IPO priced at $9.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

BSTI

BEST Inc

20:33
09/19/17
09/19
20:33
09/19/17
20:33
Syndicate
Best Inc 45M share IPO priced at $10.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

GIS

General Mills

$55.38

-1.05 (-1.86%)

20:25
09/19/17
09/19
20:25
09/19/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

PCRX

Pacira

$35.70

-0.6 (-1.65%)

20:00
09/19/17
09/19
20:00
09/19/17
20:00
Recommendations
Pacira analyst commentary at BMO Capital »

Pacira's Exparel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AVEVF

Aveva

19:56
09/19/17
09/19
19:56
09/19/17
19:56
Upgrade
Aveva rating change at Goldman Sachs »

Aveva upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZLAB

Zai Lab

18:58
09/19/17
09/19
18:58
09/19/17
18:58
Syndicate
Zai Lab announces upsizing of U.S. IPO of American depositary shares »

Zai Lab announces its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

OHI

Omega Healthcare

$32.53

-0.12 (-0.37%)

18:30
09/19/17
09/19
18:30
09/19/17
18:30
Hot Stocks
Omega Healthcare provides hurricane update »

Omega Healthcare provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

F

Ford

$11.72

0.09 (0.77%)

18:30
09/19/17
09/19
18:30
09/19/17
18:30
Periodicals
Ford to slash production at five North American assembly plants, Reuters says »

Ford announced it intends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 26

    Oct

FDX

FedEx

$216.00

0.92 (0.43%)

18:26
09/19/17
09/19
18:26
09/19/17
18:26
Hot Stocks
FedEx says without cyberattack FY18 guidance would not have changed »

Comments are from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

EE

El Paso Electric

$54.85

0.05 (0.09%)

18:25
09/19/17
09/19
18:25
09/19/17
18:25
Hot Stocks
El Paso Electric announces City of El Paso approved settlement terms »

El Paso Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

18:17
09/19/17
09/19
18:17
09/19/17
18:17
Hot Stocks
Bed Bath & Beyond says biggest component in drop of FY17 EPS view is operations »

Company dropped its FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CPRT

Copart

$32.54

-0.32 (-0.97%)

18:11
09/19/17
09/19
18:11
09/19/17
18:11
Earnings
Copart reports Q4 EPS 30c, consensus 29c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

STLD

Steel Dynamics

$33.83

0.03 (0.09%)

18:04
09/19/17
09/19
18:04
09/19/17
18:04
Earnings
Steel Dynamics sees Q3 adjusted EPS 63c-67c, consensus 70c »

Steel Dynamics provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XBKS

Xenith Bankshares

$29.96

0.42 (1.42%)

17:58
09/19/17
09/19
17:58
09/19/17
17:58
Hot Stocks
Treasury exits stake in Xenith Bankshares »

Xenith Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$62.93

0.23 (0.37%)

17:54
09/19/17
09/19
17:54
09/19/17
17:54
Periodicals
Breaking Periodicals news story on Bristol-Myers »

Times:NHS will supply…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 18

    Oct

  • 26

    Oct

  • 09

    Nov

  • 05

    Mar

BBBY

Bed Bath & Beyond

17:54
09/19/17
09/19
17:54
09/19/17
17:54
Hot Stocks
Breaking Hot Stocks news story on Bed Bath & Beyond »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

DESP

Despegar.com

17:52
09/19/17
09/19
17:52
09/19/17
17:52
Syndicate
Despegar.com 12.7M share IPO priced at $26.00 »

The IPO priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

WAC

Walter Investment

$0.65

0.186 (40.09%)

17:50
09/19/17
09/19
17:50
09/19/17
17:50
Hot Stocks
Walter Investment says Barclays to increase financing available »

On September 13, Walter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

17:49
09/19/17
09/19
17:49
09/19/17
17:49
Initiation
CymaBay initiated at Cantor »

CymaBay initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

BBBY

Bed Bath & Beyond

17:46
09/19/17
09/19
17:46
09/19/17
17:46
Hot Stocks
Bed Bath & Beyond sees net drop in Bed Bath & Beyond stores in FY17 »

Says rate of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

EVH

Evolent Health

$15.65

-0.8 (-4.86%)

17:45
09/19/17
09/19
17:45
09/19/17
17:45
Initiation
Evolent Health initiated at KeyBanc »

Evolent Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

BPL

Buckeye Partners

$56.33

0.64 (1.15%)

17:44
09/19/17
09/19
17:44
09/19/17
17:44
Syndicate
Buckeye Partners announces $210M in limited partnership unit sales »

Buckeye Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RL

Ralph Lauren

$91.03

0.87 (0.96%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Initiation
Ralph Lauren initiated at Barclays »

Ralph Lauren initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

PVH

PVH Corp.

$127.47

-0.54 (-0.42%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Initiation
PVH Corp. initiated at Barclays »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

, ORIG

Ocean Rig UDW

$0.16

-0.0083 (-4.90%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Gemphire…

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

ORIG

Ocean Rig UDW

$0.16

-0.0083 (-4.90%)

IOVA

Iovance Biotherapeutics

$8.55

0.3 (3.64%)

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

FDX

FedEx

$216.00

0.92 (0.43%)

ADBE

Adobe

$156.60

0.83 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

  • 25

    Sep

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.